Arch Intern Med. 1991 Oct;151(10):1971-6.

Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group.

Kleerekoper M, Brienza RS, Schultz LR, Johnson CC.

Source

Division of Bone and Mineral, Henry Ford Hospital, Detroit, MI 48202.

Abstract

This cross-sectional retrospective epidemiologic study investigated risk factors for low bone mineral density (BMD) in a group of 2297 women, 76% of whom were postmenopausal. Reproductive information, history of oral contraceptive use, BMD measurements, and other data were available from women presenting to 12 osteoporosis screening centers in 1986 and 1987. Each woman was classified into a BMD category based on the range of BMD measurements at her respective center. Menopause, increasing age and years since menopause, and decreasing body mass index were associated with low BMD. A history of oral contraceptive use was protective against low BMD (odds ratio = 0.35, 95% confidence interval = 0.23 to 0.53). Multivariate analyses confirmed this result and further demonstrated that increasing duration of use was protective. These data suggest that prior use of oral contraceptive agents is associated with higher levels of BMD and that the degree of protection from lower BMD is related to duration of exposure.

PMID:: 1929685; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

Contraceptives, Oral

LinkOut - more resources

Full Text Sources

EBSCO

Other Literature Sources

COS Scholar Universe

Medical

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Bone mineral density and history of oral contraceptive use. [J Reprod Med. 1994]
Bone mineral density and history of oral contraceptive use.
Fortney JA, Feldblum PJ, Talmage RV, Zhang J, Godwin SE. J Reprod Med. 1994 Feb; 39(2):105-9.
Review Oral contraceptives for the prevention of osteoporosis. [J Reprod Med. 1993]
Review Oral contraceptives for the prevention of osteoporosis.
Corson SL. J Reprod Med. 1993 Dec; 38(12 Suppl):1015-20.
Bone mineral density and depot medroxyprogesterone acetate. [Contraception. 2006]
Bone mineral density and depot medroxyprogesterone acetate.
Albertazzi P, Bottazzi M, Steel SA. Contraception. 2006 Jun; 73(6):577-83. Epub 2006 Apr 27.
Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study. [CMAJ. 2001]
Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study.
Prior JC, Kirkland SA, Joseph L, Kreiger N, Murray TM, Hanley DA, Adachi JD, Vigna YM, Berger C, Blondeau L, et al. CMAJ. 2001 Oct 16; 165(8):1023-9.
Review Low-dose oral contraceptives and bone mineral density: an evidence-based analysis. [Contraception. 2000]
Review Low-dose oral contraceptives and bone mineral density: an evidence-based analysis.
Kuohung W, Borgatta L, Stubblefield P. Contraception. 2000 Feb; 61(2):77-82.

See reviews... See all...

Cited by 4 PubMed Central articles

The effect of past use of oral contraceptive on bone mineral density, bone biochemical markers and muscle strength in healthy pre and post menopausal women. [BMC Womens Health. 2009]
The effect of past use of oral contraceptive on bone mineral density, bone biochemical markers and muscle strength in healthy pre and post menopausal women.
Allali F, El Mansouri L, Abourazzak F, Ichchou L, Khazzani H, Bennani L, Abouqal R, Hajjaj-Hassouni N. BMC Womens Health. 2009 Nov 3; 9:31. Epub 2009 Nov 3.
Past oral contraceptive use and current dietary soy isoflavones influence estrogen metabolism in postmenopausal monkeys (Macaca fascicularis). [Cancer Epidemiol Biomarkers Pr...]
Past oral contraceptive use and current dietary soy isoflavones influence estrogen metabolism in postmenopausal monkeys (Macaca fascicularis).
Scott LM, Xu X, Veenstra TD, Tooze JA, Wood CE, Register TC, Kock ND, Cline JM. Cancer Epidemiol Biomarkers Prev. 2008 Oct; 17(10):2594-602.
The influence of lifestyle, menstrual function and oral contraceptive use on bone mass and size in female military cadets. [Nutr Metab (Lond). 2007]
The influence of lifestyle, menstrual function and oral contraceptive use on bone mass and size in female military cadets.
Ruffing JA, Nieves JW, Zion M, Tendy S, Garrett P, Lindsay R, Cosman F. Nutr Metab (Lond). 2007 Aug 6; 4:17. Epub 2007 Aug 6.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Os...
Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group.
Arch Intern Med. 1991 Oct ;151(10):1971-6.

PubMed
Identification of paraxanthine as the most potent caffeine-derived inhibitor of ...
Identification of paraxanthine as the most potent caffeine-derived inhibitor of connective tissue growth factor expression in liver parenchymal cells.
Liver Int. 2009 Jul ;29(6):886-97. Epub 2009 Mar 5 .

PubMed
Use of mass isotopomer distributions in secreted lipids to sample lipogenic acet...
Use of mass isotopomer distributions in secreted lipids to sample lipogenic acetyl-CoA pool in vivo in humans.
Am J Physiol. 1991 Oct ;261(4 Pt 1):E479-86.

PubMed
The plasma zinc/serum copper ratio as a biomarker in children with autism spectr...
The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders.
Biomarkers. 2009 May ;14(3):171-80.

PubMed
Regulation of expression of the fatty acid synthase gene in 3T3-L1 cells by diff...
Regulation of expression of the fatty acid synthase gene in 3T3-L1 cells by differentiation and triiodothyronine.
J Biol Chem. 1991 Oct 5 ;266(28):18550-4.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: